Head-to-Head

Amylyx Pharmaceuticals, Inc. Common Stock vs. Johnson & Johnson

AMLX

Amylyx Pharmaceuticals, Inc. Common Stock

$29.50 +6.81%

VS JNJ

Johnson & Johnson

$283.11 +0.96%

Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) comes out ahead, leading on 2 of 3 compared factors.

Size & Scale

AMLXJNJ
Market Cap $3.79 billion $675.03 billion

JNJ leads on 1 of 1 size & scale factors.

Dividend

AMLXJNJ
Dividend Yield 5.69% 1.89%

AMLX leads on 1 of 1 dividend factors.

Risk & Sentiment

AMLXJNJ
Short Interest 0.00% 0.67%

AMLX leads on 1 of 1 risk & sentiment factors.

Dig deeper: AMLX overview, AMLX financials, JNJ overview, JNJ financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.